CONCLUSIONS: The proportion of CSU patients that achieved remission or a well-controlled state was 39% for the 6 months of stepwise treatment. Longer observations are necessary to assess the exact prognosis of CSU. ASST results may be a useful parameter for predicting a better response to treatment and both UAS and CU-QoL are helpful to monitor therapeutic response. PMID: 26739404 [PubMed] (Source: Allergy, Asthma and Immunology Research)
from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader http://ift.tt/207D14j
via IFTTT
from #Med Blogs by Alexandros G.Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/1Ja7lan
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου